Effect of unani medicine in vomiting in pregnancy
Phase 3
Completed
- Conditions
- Health Condition 1: null- Nausea and vomiting in pregnancy
- Registration Number
- CTRI/2018/03/012345
- Lead Sponsor
- ational institute of unani medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Pregnant woman with nausea and vomiting
Singleton intrauterine pregnancy
Gestational age range 7 to 14 weeks
Exclusion Criteria
Hyperemesis gravidarum and women treated by other antiemetics and patient with any medical conditions associated with pregnancy like severe anemia and hypertension and diabetes melllitus and women with history of other non obstetrical causes of vomiting like appendicitis and cholecystitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in nausea and vomiting in pregnancyTimepoint: Two weeks
- Secondary Outcome Measures
Name Time Method Change in PUQE (Pregnancy Unique Quantification of Emesis) <br/ ><br> and NVPQOL (Nausea and vomiting in pregnancy-specific Quality of life questionnaire) <br/ ><br> <br/ ><br>Timepoint: Two weeks